SETDB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.609100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.901400E-01
Normal-vs-Stage2
9.419900E-04
Normal-vs-Stage3
1.390980E-01
Normal-vs-Stage4
1.673600E-01
Stage1-vs-Stage2
1.256390E-01
Stage1-vs-Stage3
5.824400E-02
Stage1-vs-Stage4
1.297410E-01
Stage2-vs-Stage3
2.534000E-01
Stage2-vs-Stage4
5.442800E-01
Stage3-vs-Stage4
3.672000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.776500E-04
Normal-vs-AfricanAmerican
7.564000E-02
Normal-vs-Asian
1.258380E-02
Caucasian-vs-AfricanAmerican
5.289000E-01
Caucasian-vs-Asian
4.734800E-01
AfricanAmerican-vs-Asian
3.287200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.365300E-04
Normal-vs-Female
1.259150E-03
Male-vs-Female
7.107600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.435000E-01
Normal-vs-Age(41-60Yrs)
2.182800E-01
Normal-vs-Age(61-80Yrs)
9.775100E-04
Normal-vs-Age(81-100Yrs)
2.510200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.248000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.838440E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.860400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.319970E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.892000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.089400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.877000E-03
Normal-vs-Daily Drinker
1.573430E-01
Normal-vs-Weekly Drinker
5.361400E-03
Normal-vs-Occasional Drinker
1.833420E-01
Normal-vs-Social Drinker
2.383600E-02
Non Drinker-vs-Daily Drinker
3.312400E-01
Non Drinker-vs-Weekly Drinker
7.823200E-01
Non Drinker-vs-Occasional Drinker
9.056600E-01
Non Drinker-vs-Social Drinker
3.283400E-01
Daily Drinker-vs-Weekly Drinker
5.630800E-01
Daily Drinker-vs-Occasional Drinker
3.863400E-01
Daily Drinker-vs-Social Drinker
6.922300E-02
Weekly Drinker-vs-Occasional Drinker
8.540600E-01
Weekly Drinker-vs-Social Drinker
2.650200E-01
Occasional Drinker-vs-Social Drinker
2.692200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.260400E-02
Normal-vs-Grade 2
3.118200E-02
Normal-vs-Grade 3
5.611500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.754600E-01
Grade 1-vs-Grade 3
7.475600E-01
Grade 1-vs-Grade 4
7.260400E-02
Grade 2-vs-Grade 3
7.875200E-01
Grade 2-vs-Grade 4
3.118200E-02
Grade 3-vs-Grade 4
5.611500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.036100E-03
Normal-vs-NonDiabetic
1.802580E-01
Diabetic-vs-NonDiabetic
5.101400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.156100E-03
Normal-vs-NoPancreatitis
1.864980E-01
Pancreatitis-vs-NoPancreatitis
7.019600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.948830E-01
Normal-vs-N1
9.609500E-04
N0-vs-N1
7.437000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.844590E-01
Normal-vs-TP53-NonMutant
2.845000E-01
TP53-Mutant-vs-TP53-NonMutant
6.016600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
